Akebia Therapeutics Inc. buy StockNews.com
Start price
20.04.24
/
50%
€1.28
Target price
20.04.25
-
Performance (%)
1.48%
Price
22:26
€1.30
Summary
This prediction is currently active. The BUY prediction by StockNews_com shows slight gains of 1.48%. This prediction currently runs until 20.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Akebia Therapeutics Inc. | 10.289% |
iShares Core DAX® | 2.831% |
iShares Nasdaq 100 | 2.918% |
iShares Nikkei 225® | 2.007% |
iShares S&P 500 | 2.257% |
Comments by StockNews_com for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for AKBA provided by MarketBeat